GLY145ARG mutation emerging under HBIG treatment in patients with recurrent HBV after liver transplantation strongly reduces viral secretion

被引:4
作者
Fischer, L
Kalinina, T
Rogiers, X
Will, H
Sterneck, M
机构
[1] Univ Hamburg, Hosp Eppendorf, Dept Surg, D-20246 Hamburg, Germany
[2] Heinrich Pette Inst, Dept Virol, Hamburg, Germany
关键词
D O I
10.1016/S0041-1345(01)02563-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:3633 / 3636
页数:4
相关论文
共 7 条
[1]  
DAVIES SE, 1991, HEPATOLOGY, V13, P150, DOI 10.1002/hep.1840130122
[2]   Setting the standards: Quality control in the secretory pathway [J].
Ellgaard, L ;
Molinari, M ;
Helenius, A .
SCIENCE, 1999, 286 (5446) :1882-1888
[3]  
Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1
[4]   A NOVEL SIGNAL-TRANSDUCTION PATHWAY FROM THE ENDOPLASMIC-RETICULUM TO THE NUCLEUS IS MEDIATED BY TRANSCRIPTION FACTOR NF-KAPPA-B [J].
PAHL, HL ;
BAEUERLE, PA .
EMBO JOURNAL, 1995, 14 (11) :2580-2588
[5]   Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation [J].
Protzer-Knolle, U ;
Naumann, U ;
Bartenschlager, R ;
Berg, T ;
Hopf, U ;
zum Buschenfelde, KHM ;
Neuhaus, P ;
Gerken, G .
HEPATOLOGY, 1998, 27 (01) :254-263
[6]   Advertising intimacy: Relationship marketing and the services consumer [J].
Stern, BB .
JOURNAL OF ADVERTISING, 1997, 26 (04) :7-19
[7]  
Wang XZ, 1996, MOL CELL BIOL, V16, P4273